Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sight Sciences (SGHT) Research & Development (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Research & Development data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Research & Development fell 43.23% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $14.6 million, down 18.81%, while the annual FY2025 figure was $14.6 million, 18.81% down from the prior year.
  • Research & Development reached $2.4 million in Q4 2025 per SGHT's latest filing, down from $3.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $6.1 million in Q3 2022 and bottomed at $2.4 million in Q4 2025.
  • Average Research & Development over 5 years is $4.4 million, with a median of $4.4 million recorded in 2021.
  • Peak YoY movement for Research & Development: surged 145.74% in 2021, then crashed 43.23% in 2025.
  • A 5-year view of Research & Development shows it stood at $4.4 million in 2021, then rose by 19.78% to $5.2 million in 2022, then crashed by 34.51% to $3.4 million in 2023, then rose by 25.27% to $4.3 million in 2024, then plummeted by 43.23% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $2.4 million in Q4 2025, $3.4 million in Q3 2025, and $4.4 million in Q2 2025.